Applied BioCode Corporation - Laporan Laba Rugi (TTM)

Applied BioCode Corporation
TW ˙ TWSE
NT$ 20.85 ↓ -1.15 (-5.23%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Applied BioCode Corporation menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 186 299 331 388 349 320 290 330 379 390 419 390 388 395 394 417 386 343 382 396
Change (%) 60.48 10.85 16.93 -9.97 -8.31 -9.32 13.77 14.84 2.96 7.34 -6.99 -0.52 1.93 -0.31 5.88 -7.39 -11.19 11.22 3.74
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 79 105 110 140 138 131 133 131 142 156 155 156 149 126 126 129 125 139 149 171
Change (%) 33.63 4.68 27.05 -1.55 -5.45 2.12 -1.92 8.67 9.84 -0.92 0.91 -4.77 -14.94 -0.00 2.26 -3.50 11.47 7.05 14.72
% of Revenue 42.37 35.28 33.31 36.20 39.58 40.82 45.96 39.63 37.50 40.00 36.92 40.06 38.34 31.99 32.09 30.99 32.29 40.54 39.02 43.15
Gross Operating Profit 107 194 221 247 211 189 157 199 237 234 264 234 239 269 268 288 262 204 233 225
Change (%) 80.22 14.22 11.87 -14.74 -10.18 -17.21 27.11 18.89 -1.17 12.85 -11.61 2.33 12.43 -0.45 7.59 -9.13 -22.01 14.06 -3.29
% of Revenue 57.63 64.72 66.69 63.80 60.42 59.18 54.04 60.37 62.50 60.00 63.08 59.94 61.66 68.01 67.91 69.01 67.71 59.46 60.98 56.85
SG&A 121 130 134 134 140 148 158 166 179 188 193 204 213 209 215 212 208 209 205 198
Change (%) 7.48 3.27 -0.36 4.47 6.22 6.51 5.25 7.38 5.42 2.65 5.41 4.45 -1.64 2.52 -1.39 -1.99 0.86 -2.19 -3.29
% of Revenue 64.93 43.49 40.51 34.52 40.05 46.40 54.50 50.42 47.14 48.27 46.16 52.31 54.93 53.00 54.50 50.76 53.71 61.01 53.65 50.02
R&D 190 197 200 197 199 206 213 224 235 238 244 238 237 246 254 266 273 273 279 296
Change (%) 3.78 1.58 -1.64 0.86 3.69 3.42 5.45 4.69 1.42 2.28 -2.51 -0.26 3.77 3.35 4.58 2.85 -0.31 2.52 5.79
% of Revenue 101.88 65.88 60.37 50.79 56.89 64.34 73.37 68.01 62.00 61.07 58.19 60.99 61.15 62.25 64.54 63.75 70.79 79.46 73.25 74.69
OpEx 390 433 445 471 476 485 504 522 556 583 592 598 599 582 595 607 606 621 633 664
Change (%) 10.98 2.84 5.87 1.17 1.78 4.02 3.44 6.55 4.86 1.54 0.97 0.17 -2.80 2.32 1.94 -0.19 2.52 1.95 4.95
% of Revenue 209.18 144.65 134.20 121.50 136.53 151.55 173.83 158.05 146.64 149.35 141.28 153.36 154.42 147.25 151.13 145.50 156.80 181.01 165.92 167.86
Operating Income -203 -134 -113 -83 -127 -165 -214 -192 -177 -193 -173 -208 -211 -187 -201 -190 -219 -278 -252 -269
Change (%) -34.37 -15.10 -26.47 52.95 29.39 29.88 -10.55 -7.74 8.94 -10.21 20.24 1.46 -11.50 7.88 -5.78 15.61 26.66 -9.50 6.79
% of Revenue -109.18 -44.65 -34.20 -21.50 -36.53 -51.55 -73.83 -58.05 -46.64 -49.35 -41.28 -53.36 -54.42 -47.25 -51.13 -45.50 -56.80 -81.01 -65.92 -67.86
Interest Expense -6 -4 -4 -3 -3 -3 -3 -3 -3 -3 -3 -3 -2 -2 -2 -2 -2 -1 -1 -1
Change (%) -29.28 -16.67 -12.85 -5.94 -2.58 -2.16 -3.31 4.42 -1.80 -3.63 -2.46 -10.05 -7.99 -7.85 -8.37 -10.77 -12.56 -13.24 -14.94
% of Revenue -3.27 -1.44 -1.08 -0.81 -0.84 -0.90 -0.97 -0.82 -0.75 -0.71 -0.64 -0.67 -0.61 -0.55 -0.51 -0.44 -0.42 -0.42 -0.32 -0.27
Net Income -208 -103 -83 -54 -92 -165 -215 -192 -175 -185 -162 -191 -191 -164 -177 -165 -199 -261 -233 -251
Change (%) -50.36 -20.16 -34.42 70.16 79.14 30.21 -10.75 -8.85 5.57 -12.50 18.30 -0.20 -13.96 7.55 -6.32 20.01 31.37 -10.50 7.51
% of Revenue -111.89 -34.61 -24.93 -13.98 -26.43 -51.63 -74.14 -58.16 -46.16 -47.33 -38.58 -49.07 -49.22 -41.55 -44.82 -39.66 -51.39 -76.02 -61.18 -63.40

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista